Insulin Manufacturers Employ Strategies to Extend Market Exclusivity

TUESDAY, Nov. 21, 2023 -- Insulin manufacturers have employed strategies to extend periods of market exclusivity on brand-name insulin products, including filing patents after U.S. Food and Drug Administration approval, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news